Page last updated: 2024-11-07

methylprednisolone acetate and Central Nervous System Diseases

methylprednisolone acetate has been researched along with Central Nervous System Diseases in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dawley, JD1
Moeller-Bertram, T1
Wallace, MS1
Patel, PM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparative Effectiveness of Particulate Versus Nonparticulate Corticosteroid Injections for the Treatment of Musculoskeletal Conditions[NCT04278833]Phase 4198 participants (Anticipated)Interventional2020-09-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for methylprednisolone acetate and Central Nervous System Diseases

ArticleYear
Intra-arterial injection in the rat brain: evaluation of steroids used for transforaminal epidurals.
    Spine, 2009, Jul-15, Volume: 34, Issue:16

    Topics: Analgesia, Epidural; Animals; Blood-Brain Barrier; Brain; Carotid Artery, External; Central Nervous

2009